STOCKWATCH
·
Biological Products, (No Diagnostic Substances)
AcquisitionsApr 13, 2026, 09:20 AM

BiomX Acquires Controlling Interest in DFSL, Expands Defense Portfolio

AI Summary

BiomX Inc. has accelerated its option to acquire a controlling interest in DFSL, an Israeli defense engineering company specializing in LADAR-based detection systems. This strategic move expands BiomX's presence in the defense sector, adding high-precision, real-time threat tracking capabilities to its portfolio. The acquisition complements BiomX's recently acquired Zorronet AI command-and-control platform, creating an integrated system for detection, analysis, and response in defense, critical infrastructure, and first-response applications.

Key Highlights

  • BiomX acquired a controlling interest in DFSL, an Israeli defense engineering company.
  • DFSL develops proprietary LADAR-based detection systems for security and counter-UAS markets.
  • This acquisition adds a second, complementary capability to BiomX's defense portfolio.
  • DFSL's LADAR technology offers real-time tracking of aerial and ground threats with 99% accuracy.
  • The acquisition integrates with BiomX's recently acquired Zorronet AI command-and-control platform.
PHGE
Biological Products, (No Diagnostic Substances)
BiomX Inc.

Price Impact